Palantir's Commercial Strategy Is Finally Paying Off
AIP powers real operational AI, not demos.
Cloud partnerships are unlocking new opportunities.
Palantir's commercial success isn't just theoretical, it's backed by real-world examples of customer adoption.
10 stocks we like better than Palantir Technologies ›
Palantir Technologies (NASDAQ: PLTR) has long been recognized for its work in the shadows -- helping government agencies, such as the Department of Defense and the CIA, make sense of vast amounts of data.
But for years, investors questioned whether it could ever succeed in the commercial world. While the company often emphasized commercial expansion, the numbers have historically lagged behind those of its core government business.
But that's changing -- and fast. Today, Palantir's commercial business is not just growing, it's accelerating. Thanks to the interest in artificial intelligence (AI) and the company's strategy, it may finally be building a sustainable and scalable engine outside public business.
AIP is the inflection point
Palantir's Artificial Intelligence Platform (AIP) is emerging as its breakout commercial product. Launched as the fourth platform after Gotham, Foundry, and Apollo, AIP is Palantir's answer to the rapid rise in demand for enterprise AI solutions.
Commercial customers can use it to integrate large language models (LLMs) into their internal data workflows, all while preserving the security, governance, and compliance that Palantir is known for. AIP enables enterprises to build and scale AI agents with full access controls, audit trails, and encryption baked in. With AIP, customers can immediately see tangible benefits in areas such as automation, problem-solving, and workflow improvements without compromising on data and security requirements.
Palantir has also rolled out AIP boot camps, five-day hands-on workshops that help companies go from zero to a working AI use case using their internal data. Customers don't just learn how to prompt -- they architect LLM-powered workflows, evaluate fine-tuning vs. prompting, and build real systems. For some customers, boot camps have helped them resolve problems they'd been wrestling with for years.
Not surprisingly, these efforts have yielded tangible improvements in financial metrics. In the first quarter of 2025, U.S. commercial revenue increased 71% year over year to $255 million, and U.S. commercial total contract value (TCV) bookings rose 183% to $810 million. The U.S. commercial customer count also grew 65% to 432.
Strategic cloud partnerships could be an important growth lever
Beyond the launch of AIP and AIP boot camp, Palantir has also expanded its partnerships with cloud giants to integrate its AI platform within the ecosystems that customers already use.
With Google Cloud, Palantir launched Foundry and AIP integrations for commercial clients in retail, healthcare, and logistics. With that, companies leverage BigQuery and other Google Cloud services while tapping into Palantir's data modeling and orchestration tools.
On Amazon Web Services (AWS), Palantir is working with enterprise clients to run AIP workloads using Claude and other models. A major U.S. insurer, for example, used AIP on AWS to reduce underwriting times from two weeks to just three hours.
These integrations remove key roadblocks to adoption. Besides, these partnerships are a win-win-win. Customers don't have to rip and replace their existing infrastructure. Cloud providers retain clients within their ecosystem. And Palantir gains distribution and scale.
Real-world examples of customer adoption
Palantir's commercial success isn't theoretical. It's happening in the field.
For instance, Heineken transformed its supply chain using AI agents to optimize delivery and shipping. With the help of AIP, the team was able to build what had previously taken them three years in just three months.
AIG, an insurance giant, expects the adoption of AIP to aid in AI-powered underwriting, aiming to double its five-year revenue growth rate from 10% to 20%. This example suggests that AIP not only helps improve efficiency, but also acts as an enabler in increasing the top line.
Another example is Rio Tinto, which leverages the Foundry and AIP platforms to orchestrate and optimize train routes and maintenance needs for dozens of unmanned trains running 24/7.
These examples show that AIP isn't just a shiny front end for AI experimentation -- it's delivering real outcomes across industries.
What it means for investors
Palantir's long-awaited commercial pivot is finally delivering tangible results.
With AIP gaining traction and strategic partnerships expanding its reach, Palantir is transforming from a government-first software vendor into a scalable enterprise AI company.
But while the growth is promising, investors should approach with measured optimism. Palantir trades at a rich valuation, reflecting high expectations for future expansion. At the time of this writing, the stock has a price-to-sales (P/S) ratio of 121.
So, the key question is whether Palantir can sustain this momentum into the future. If the company continues to deliver strong commercial wins, and the valuation becomes more attractive, this could be a compelling long-term investment opportunity.
All said, investors should keep the stock on their watchlist.
Should you buy stock in Palantir Technologies right now?
Before you buy stock in Palantir Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,149!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,060,406!*
Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 15, 2025
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Lawrence Nga has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon and Palantir Technologies. The Motley Fool has a disclosure policy.
Palantir's Commercial Strategy Is Finally Paying Off was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications
HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics'), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the filing of a patent application with the United States Patent and Trademark Office covering methods of generating multipotent cells from fibroblasts found in donor tissue for clinical applications. Multipotency refers to a flexible cellular state in which a cell has the potential to differentiate into multiple specialized cell types, depending on the environmental conditions or stimuli it encounters. While stem cells have garnered the most attention on being multipotent, fibroblasts are also considered multipotent and can be directly differentiated into many cell types including chondrocytes, osteocytes, hepatocytes and cardiomyocytes. This patent application broadly relates to methods for generating multipotent cells directly from fibroblasts found in human donor tissues. 'This method provides us with the ability to obtain larger quantities of stable and easily scalable multipotent cells from donor-derived fibroblasts for use in clinical applications,' said Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics. 'Multipotent fibroblasts also show enhanced ability to form 3D spheroid structures, further expanding their potential across a range of therapeutic and drug development areas.' Pete O'Heeron, Founder and Chief Executive Officer of FibroBiologics, said, 'By enabling the generation of stable, multipotent cells directly from donor tissue, this innovation addresses long-standing challenges in the field and opens new possibilities for scalable, regenerative treatments.' For more information, please visit FibroBiologics' website or email FibroBiologics at info@ Cautionary Statement Regarding Forward-Looking Statements This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the potential of multipotent fibroblasts across a range of therapeutic and drug development areas and new possibilities for scalable, regenerative treatments. These forward-looking statements are based on FibroBiologics' management's current expectations, estimates, projections and beliefs, as well as a number of assumptions concerning future events. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside FibroBiologics' management's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including those set forth under the caption "Risk Factors" and elsewhere in FibroBiologics' annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. Copies are available on the SEC's website, These risks, uncertainties, assumptions and other important factors include, but are not limited to: (a) risks related to FibroBiologics' liquidity and its ability to maintain capital resources sufficient to conduct its business; (b) expectations regarding the initiation, progress and expected results of our R&D efforts and preclinical studies; (c) the unpredictable relationship between R&D and preclinical results and clinical study results; and (d) the ability of FibroBiologics to successfully prosecute its patent applications. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FibroBiologics assumes no obligation and, except as required by law, does not intend to update, or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. FibroBiologics gives no assurance that it will achieve its expectations. About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit General Inquiries:info@ Investor Relations:Nic JohnsonRusso Partners(212) 845-4242fibrobiologicsIR@ Media Contact:Liz PhillipsRusso Partners(347) in to access your portfolio
Yahoo
23 minutes ago
- Yahoo
"'Oh, This Is Whole Foods?'": People Share Their Experiences With Very, Very Wealthy Friends, And I'm Genuinely Shocked At How Out Of Touch They Are
Unfortunately, wealth disparity exists in this world. Cough — the Bezos-Sánchez $50 million wedding comes to mind. In r/ask, when someone asked, "Something your rich friends have said that made your jaw drop?", people weighed in on how this exists all around us. And wow, what a peek into a gilded reality. Here's what people had to say: 1."A group of us went to McDonald's, and after he got his cheeseburger, he went back to the counter to ask them to center his cheese." —bunk3rk1ng 2."'I don't get it. What would he need two jobs for?'" —superkow 3."I accidentally found out that what I made in a year, working full time, he made in a month. Yeah, I knew he was wealthy, but that put it into perspective." —Interesting_Day2277 4."I had the 17-year-old daughter of a rich acquaintance visit our city with a few of her friends for spring break. I was helping her check into their hotel (the most expensive one in the city) when she decided she didn't like the suite and wondered if an upgrade was available. Indeed, there was —the penthouse, but it would cost an additional $8k or more. Without batting an eye, she whips out HER CREDIT CARD and says, 'Use this one.' A 17-year-old with a five-digit credit card limit, who didn't need her parents' permission to use it, just blew my mind." —Middle-Luck-997 5."I was a council house kid. I went to school with lots of better-off kids and some rich ones. Some were OK, but some didn't seem to understand, or care, for that matter. What gets me is the calm acceptance. You want a new bicycle? Here, have one. Clothes? Sure, have what you like. A Bang & Olufsen stereo for your room? Here it is, son. Motorbikes, cars, even houses. No problem. Must be nice to have 'stuff,' although some of the parents weren't that interested in their kids from what I could see. A couple of the blokes I've known later in life who came from monied families, reckoned they were basically treated as an inconvenience, and packed off to boarding school as soon as possible." WB / Via —Amplidyne 6."Not friends, but some estranged family I've recently connected with dropped this line: 'We're middle class.' Yet, they own three houses, multiple business ventures, and she does triathlons all over the world. They just extended their vacation in, I think, Guam, because she wanted to adopt two dogs off the street, but couldn't bring them home during their current vacation time due to the pups' health concerns. Completely out of touch. Also, they asked me, 'Why do you guys rent in San Diego when you could just buy a house instead and build up the equity?' Like that's a possibility." —nobeer4you 7."'We'll keep it small, just a few friends over.' It turned out to be a 50-person party with wedding-worthy flowers, an eight-person catering staff, and two live entertainment acts. 12 people I didn't know brought presents for my son." —NightSisterSally 8."'I traveled economy once. Ugh, it was so narrow.'" —shiroandae 9."'How did your parents invest the money they saved for you?' Bro. My parents didn't save money for me. They fed me, clothed me, supported me, and paid for some extracurriculars. I'm grateful. Not all parents have the ability to save as well." —Foreign-Yak-3223 10."One didn't notice an entire family gym membership leaking out of their bank account for a year. They thought they'd canceled it. It was £300 a month." —South-Bank-stroll 11."'We need poor people for society to function.'" —Poulop 12."Their parent's salary equates to my lifetime income." —Intelligent_Way_9450 13."His parents bought him a house near the university because they didn't see the point in paying for a year of rent." —Financial_Change_183 14."A friend from uni gave me a ride in a $50k Mercedes. I said it was a cool car, and he said, 'You should have seen the other one,' but he crashed it. It was a $100k car. Mind you, we were 18 and 19 at the time." —SignalElderberry600 15."A best friend growing up got a full ride to go to college, even though he was filthy rich. Our friend group was talking about student loans, and he chimed in, saying he took out $20k in loans and spent it on shoes and liquor because that's what college is about. We stopped talking." —Cocoononthemoon 16."A woman I worked for recommended a $35 mouthwash to me. It was 1.5 ounces." —chudock74 17."I heard a rich guy say that people don't use the word groceries anymore." —Hister333 "What does he mean?" —PassengerNo2022 18."I went to Whole Foods with my friend, and he said, 'Oh, this is Whole Foods? So, this is where [House Manager Name] goes to get our food!'" —Dull_Wrongdoer_3017 19."On what to do for my 18th birthday, she suggested flying my friends out to another country and renting a private yacht. That would've cost $2,500 for just the tickets and the yacht, plus more, for other expenses like cabs, food, and whatnot." —SoggyDoughnut69 20."'I think my trust fund is around $9 million.' Later that day, he found out it was $23 million. This is a person in their late 30s." —sixjasefive 21."They want to go golfing in the middle of the day, on a weekday." —3rody 22."'I'm not materialistic.'" HBO / Via HBO / Via —Tak-Tik-2 finally, "'I keep spending money and more just shows up in the account.' I almost cried." —ohyesiam1234 I'm crying in pennies. Any wealthy friend stories to share? Let us know in the comments! Note: Responses have been edited for length/clarity. Solve the daily Crossword
Yahoo
23 minutes ago
- Yahoo
Alibaba Unveils AI Glasses to Rival Meta's
Alibaba Group Holdings (BABA) unveiled its first AI-powered smart glasses Monday, as the Chinese tech giant launches a wearable with features rivaling those of Meta Platforms' (META) offering with Ray-Ban. Alibaba's U.S.-listed shares, which entered Monday up more than 40% this year, are rising 1.5% in premarket trading. The Quark AI Glasses, the Chinese company's first, will be powered by Alibaba's large language model Qwen and are scheduled for official release in China by the end of the year. Alibaba's eyeglasses will be competing with those recently launched by Chinese smartphone maker Xiaomi. "Lightweight and ergonomically designed, Quark AI Glasses support hands-free calling, music streaming, real-time language translation, and meeting transcription—making them ideal for professionals, travelers, and tech-savvy users,' Alibaba said. Wearable technology such as eyeglasses or smartwatches are increasingly viewed as the next stage in AI gadgets after smartphones. Not all wearable devices have been hits, however: Google Glass was pulled by parent Alphabet (GOOGL) from the market after two failed launches since 2014. Read the original article on Investopedia Sign in to access your portfolio
